Xiaoli Cao
Impact in
- Molecular Medicine top 0.5%
- Antibiotic Resistance in Bacteria
- Endocrinology top 2%
- Enterobacteriaceae and Cronobacter Research
Papers in
-
- Circular RNAs in diseases 9
- Peroxisome Proliferator-Activated Receptors 9
-
- Antibiotic Resistance in Bacteria 34
- Co-authors
- Rui‐Xing Yin (29 shared papers)Wu‐Xian Chen (19 shared papers)Han Shen (21 shared papers)Dong‐Feng Wu (15 shared papers)Jin‐Zhen Wu (16 shared papers)Zhifeng Zhang (11 shared papers)Wanqing Zhou (18 shared papers)Lynn Htet Htet Aung (14 shared papers)
- Journals
- Lipids in Health and Disease (9 papers)Frontiers in Microbiology (6 papers)BMC Infectious Diseases (5 papers)International Journal of Molecular Sciences (3 papers)Antimicrobial Resistance and Infection Control (3 papers)
- Partner nations
- ChinaUnited StatesJapan
In The Last Decade
Xiaoli Cao
124 papers receiving 2.0k citations
Peers
Comparison fields: 5 of 133
- Molecular Medicine 507
- Endocrinology 272
- Applied Microbiology and Biotechnology 84
- Clinical Biochemistry 155
- Cancer Research 275
Countries citing papers authored by Xiaoli Cao
This map shows the geographic impact of Xiaoli Cao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoli Cao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoli Cao more than expected).
Fields of papers citing papers by Xiaoli Cao
This network shows the impact of papers produced by Xiaoli Cao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoli Cao. The network helps show where Xiaoli Cao may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiaoli Cao, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 134 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 79 | |
| 2 | 2016 | 61 | |
| 3 | 2011 | 60 | |
| 4 | 2014 | 53 | |
| 5 | 2018 | 52 | |
| 6 | 2020 | 51 | |
| 7 | 2023 | 50 | |
| 8 | 2012 | 49 | |
| 9 | 2016 | 41 | |
| 10 | 2020 | 41 | |
| 11 | 2016 | 36 | |
| 12 | 2013 | 36 | |
| 13 | 2017 | 35 | |
| 14 | 2019 | 33 | |
| 15 | 2009 | 32 | |
| 16 | 2019 | 31 | |
| 17 | 2022 | 30 | |
| 18 | 2017 | 30 | |
| 19 | 2014 | 30 | |
| 20 | 2013 | 29 |
About Xiaoli Cao
Xiaoli Cao is a scholar working on Molecular Biology, Molecular Medicine, Epidemiology, Cancer Research and Endocrinology, having authored 134 papers that have together received 2.0k indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (34 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (10 papers), MicroRNA in disease regulation (10 papers), Cancer-related molecular mechanisms research (10 papers), Circular RNAs in diseases (9 papers), Genetic Associations and Epidemiology (9 papers), Bacterial Identification and Susceptibility Testing (9 papers) and Peroxisome Proliferator-Activated Receptors (9 papers). The work is most often cited by research in Molecular Medicine (507 citations), Endocrinology (272 citations), Applied Microbiology and Biotechnology (84 citations), Clinical Biochemistry (155 citations) and Cancer Research (275 citations). Xiaoli Cao has collaborated with scholars based in China, United States and Japan. Frequent co-authors include Rui‐Xing Yin, Wu‐Xian Chen, Han Shen, Dong‐Feng Wu, Jin‐Zhen Wu, Zhifeng Zhang, Wanqing Zhou, Lynn Htet Htet Aung, Kui Zhang and Junhao Chen. Their work appears in journals such as Lipids in Health and Disease, Frontiers in Microbiology, BMC Infectious Diseases, International Journal of Molecular Sciences and Antimicrobial Resistance and Infection Control.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.